| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | dipeptidyl-peptidase activity | 2.30e-04 | 12 | 38 | 2 | GO:0008239 | |
| GeneOntologyBiologicalProcess | central nervous system segmentation | 3.47e-05 | 5 | 39 | 2 | GO:0035283 | |
| MousePheno | abnormal oviduct physiology | 5.40e-06 | 2 | 33 | 2 | MP:0012018 | |
| MousePheno | abnormal hepatic vein connection | 3.23e-05 | 4 | 33 | 2 | MP:0013973 | |
| Domain | - | 7.01e-05 | 6 | 41 | 2 | 2.140.10.30 | |
| Domain | DPPIV_N | 7.01e-05 | 6 | 41 | 2 | PF00930 | |
| Domain | Peptidase_S9B_N | 7.01e-05 | 6 | 41 | 2 | IPR002469 | |
| Domain | Peptidase_S9 | 2.55e-04 | 11 | 41 | 2 | PF00326 | |
| Domain | Peptidase_S9 | 2.55e-04 | 11 | 41 | 2 | IPR001375 | |
| Domain | PTB | 3.48e-03 | 40 | 41 | 2 | SM00462 | |
| Domain | PTB/PI_dom | 3.65e-03 | 41 | 41 | 2 | IPR006020 | |
| Pubmed | Zic4, a zinc-finger transcription factor, is expressed in the developing mouse nervous system. | 6.08e-09 | 4 | 41 | 3 | 15895369 | |
| Pubmed | Spatiotemporal expression of Zic genes during vertebrate inner ear development. | 1.81e-07 | 10 | 41 | 3 | 23606270 | |
| Pubmed | CD spectra show the relational style between Zic-, Gli-, Glis-zinc finger protein and DNA. | 1.81e-07 | 10 | 41 | 3 | 18298960 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 21711053 | ||
| Pubmed | DP8 and DP9 have extra-enzymatic roles in cell adhesion, migration and apoptosis. | 1.36e-06 | 2 | 41 | 2 | 16700509 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 23519473 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 33932609 | ||
| Pubmed | Inhibition of dipeptidyl peptidase 8/9 impairs preadipocyte differentiation. | 1.36e-06 | 2 | 41 | 2 | 26242871 | |
| Pubmed | Expression profiling of dipeptidyl peptidase 8 and 9 in breast and ovarian carcinoma cell lines. | 1.36e-06 | 2 | 41 | 2 | 22736146 | |
| Pubmed | Structural requirements for catalysis, expression, and dimerization in the CD26/DPIV gene family. | 1.36e-06 | 2 | 41 | 2 | 12534281 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 25464020 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 38458339 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 32998073 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 19581630 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 21238538 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 12522805 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 39358345 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 15866709 | ||
| Pubmed | Expression of the receptor tyrosine kinase substrate genes eps8 and eps15 during mouse development. | 4.06e-06 | 3 | 41 | 2 | 7566980 | |
| Pubmed | DPP9's Enzymatic Activity and Not Its Binding to CARD8 Inhibits Inflammasome Activation. | 4.06e-06 | 3 | 41 | 2 | 31525884 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 23608773 | ||
| Pubmed | Structural and biochemical mechanisms of NLRP1 inhibition by DPP9. | 4.06e-06 | 3 | 41 | 2 | 33731929 | |
| Pubmed | DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation. | 4.06e-06 | 3 | 41 | 2 | 33731932 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 16740656 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 29693275 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 16704418 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 12662155 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 22024047 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 24072711 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 14679585 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 33335078 | ||
| Pubmed | Overlapping and distinct expression domains of Zic2 and Zic3 during mouse gastrulation. | 4.06e-06 | 3 | 41 | 2 | 15261827 | |
| Pubmed | The mouse zic gene family. Homologues of the Drosophila pair-rule gene odd-paired. | 4.06e-06 | 3 | 41 | 2 | 8557628 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 29396289 | ||
| Pubmed | SUMOylation Potentiates ZIC Protein Activity to Influence Murine Neural Crest Cell Specification. | 8.12e-06 | 4 | 41 | 2 | 34638777 | |
| Pubmed | Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas. | 8.12e-06 | 4 | 41 | 2 | 20043068 | |
| Pubmed | An Evolutionarily Conserved Mesodermal Enhancer in Vertebrate Zic3. | 8.12e-06 | 4 | 41 | 2 | 30297839 | |
| Pubmed | [The correlation between the expression of PRL-R and ER/PR in breast cancer]. | 8.12e-06 | 4 | 41 | 2 | 20335148 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 12456789 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 11053430 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 7931345 | ||
| Pubmed | Myogenic repressor I-mfa interferes with the function of Zic family proteins. | 1.35e-05 | 5 | 41 | 2 | 15207726 | |
| Pubmed | Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver. | 1.35e-05 | 5 | 41 | 2 | 23704821 | |
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 15601848 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 20534982 | ||
| Pubmed | DPP8/DPP9 inhibition elicits canonical Nlrp1b inflammasome hallmarks in murine macrophages. | 2.03e-05 | 6 | 41 | 2 | 30718379 | |
| Pubmed | Molecular properties of Zic4 and Zic5 proteins: functional diversity within Zic family. | 2.03e-05 | 6 | 41 | 2 | 15465018 | |
| Pubmed | Physical and functional interactions between Zic and Gli proteins. | 2.03e-05 | 6 | 41 | 2 | 11238441 | |
| Pubmed | Zic2 patterns binocular vision by specifying the uncrossed retinal projection. | 2.84e-05 | 7 | 41 | 2 | 13678579 | |
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 28887018 | ||
| Pubmed | Hierarchical CRMP2 posttranslational modifications control NaV1.7 function. | 2.84e-05 | 7 | 41 | 2 | 27940916 | |
| Pubmed | Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex. | 2.84e-05 | 7 | 41 | 2 | 12192048 | |
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 35817961 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 9070329 | ||
| Pubmed | The role of Zic genes in inner ear development in the mouse: Exploring mutant mouse phenotypes. | 4.86e-05 | 9 | 41 | 2 | 25178196 | |
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 15136147 | ||
| Pubmed | A role for Zic1 and Zic2 in Myf5 regulation and somite myogenesis. | 6.07e-05 | 10 | 41 | 2 | 21211521 | |
| Pubmed | 7.41e-05 | 11 | 41 | 2 | 18547559 | ||
| Pubmed | Fibroblast growth factor 8 organizes the neocortical area map and regulates sensory map topography. | 7.41e-05 | 11 | 41 | 2 | 22623663 | |
| Pubmed | 1.22e-04 | 14 | 41 | 2 | 22588720 | ||
| Pubmed | Ubc9 fusion-directed SUMOylation identifies constitutive and inducible SUMOylation. | 1.22e-04 | 14 | 41 | 2 | 17709345 | |
| Pubmed | 1.61e-04 | 89 | 41 | 3 | 23891004 | ||
| Pubmed | 1.61e-04 | 16 | 41 | 2 | 15384171 | ||
| Pubmed | 1.82e-04 | 17 | 41 | 2 | 26025376 | ||
| Pubmed | 2.05e-04 | 18 | 41 | 2 | 17490632 | ||
| Pubmed | HIF2α in the uterine stroma permits embryo invasion and luminal epithelium detachment. | 2.29e-04 | 19 | 41 | 2 | 29911998 | |
| Pubmed | 2.54e-04 | 20 | 41 | 2 | 20716560 | ||
| Pubmed | 2.81e-04 | 21 | 41 | 2 | 36332009 | ||
| Pubmed | 2.81e-04 | 21 | 41 | 2 | 29117290 | ||
| Pubmed | 3.09e-04 | 22 | 41 | 2 | 23850713 | ||
| Pubmed | 3.09e-04 | 22 | 41 | 2 | 18448648 | ||
| Pubmed | 3.11e-04 | 506 | 41 | 5 | 30890647 | ||
| Pubmed | 3.68e-04 | 24 | 41 | 2 | 19616115 | ||
| Pubmed | 4.00e-04 | 25 | 41 | 2 | 15229182 | ||
| Pubmed | Zic1 and Zic3 regulate medial forebrain development through expansion of neuronal progenitors. | 4.00e-04 | 25 | 41 | 2 | 17507568 | |
| Pubmed | 4.33e-04 | 26 | 41 | 2 | 22992956 | ||
| Pubmed | 6.04e-04 | 329 | 41 | 4 | 17474147 | ||
| Pubmed | Genome-wide association study of periodontal pathogen colonization. | 6.17e-04 | 31 | 41 | 2 | 22699663 | |
| Pubmed | 6.30e-04 | 591 | 41 | 5 | 15231748 | ||
| Pubmed | 9.28e-04 | 38 | 41 | 2 | 19574343 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 1.10e-03 | 670 | 41 | 5 | 22990118 | |
| Cytoband | 2q31.1 | 2.59e-03 | 84 | 41 | 2 | 2q31.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 5.49e-03 | 797 | 41 | 4 | chr19p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p11 | 5.80e-03 | 127 | 41 | 2 | chr10p11 | |
| GeneFamily | CD molecules|DASH family | 4.16e-05 | 7 | 26 | 2 | 1205 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 3.20e-03 | 718 | 26 | 5 | 28 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-05 | 157 | 41 | 4 | c17c5c01fcb65c453690c265ec4f300ecdfefd34 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Cajal-Retzius|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.51e-05 | 163 | 41 | 4 | c1484e4de8b10e2f5fb14a7c02b2a015ffe0305e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 165 | 41 | 4 | dc570154baed59ed109e5369589448e075ba66a9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-05 | 173 | 41 | 4 | 0bc2aacae60c6d3276b0949eb0748b4ac1f56e54 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-05 | 176 | 41 | 4 | c2c4306476989bc2fb30dab00250ef7915842f13 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 177 | 41 | 4 | 8e4005fad50e6f919da175f3b9ae58849dbd60b1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.28e-05 | 181 | 41 | 4 | 2b53a65ca5616a7b9f64232c3e0b7212d1e2f063 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.28e-05 | 181 | 41 | 4 | 6aef84616e8d2faf54b7e9e6cd02f33c3066dabc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-05 | 181 | 41 | 4 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.28e-05 | 181 | 41 | 4 | 40df0afcb6848202da54670e84f22d7c3a515d01 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.28e-05 | 181 | 41 | 4 | 40d3829ae4aaf81e8616c3499ff8933137fc1cc4 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 187 | 41 | 4 | 7b0168bdaa7c6c6b39878aff6a17f0943189a380 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.82e-05 | 191 | 41 | 4 | cadb7a9de16f4bb21606de0e25cddd2d748c7f0b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-midbrain/hindbrain_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 3.12e-05 | 196 | 41 | 4 | 0767581b69bc7e6334d580ca02ed1e831b7b55da | |
| Drug | UAMC00132 | 3.16e-06 | 2 | 41 | 2 | ctd:C524159 | |
| Drug | SureCN3749646 | 9.48e-06 | 3 | 41 | 2 | CID011530920 | |
| Drug | SureCN3745540 | 9.48e-06 | 3 | 41 | 2 | CID011974437 | |
| Drug | SureCN3749947 | 9.48e-06 | 3 | 41 | 2 | CID011974435 | |
| Drug | ABT-279 | 9.48e-06 | 3 | 41 | 2 | CID016049769 | |
| Drug | Cyanopyrrolidine 38 | 9.48e-06 | 3 | 41 | 2 | CID010932707 | |
| Drug | Cyanopyrrolidine 39 | 9.48e-06 | 3 | 41 | 2 | CID011117606 | |
| Drug | SureCN3748611 | 9.48e-06 | 3 | 41 | 2 | CID011974325 | |
| Drug | Diprolyl-alanine | 9.48e-06 | 3 | 41 | 2 | CID000193559 | |
| Drug | Arg-pro | 1.43e-05 | 82 | 41 | 4 | CID000151003 | |
| Drug | RU 16117 | 1.72e-05 | 28 | 41 | 3 | CID000066408 | |
| Drug | glycylproline 4-nitroanilide | 1.89e-05 | 4 | 41 | 2 | ctd:C042892 | |
| Drug | hexestrol | 1.92e-05 | 29 | 41 | 3 | CID000003606 | |
| Drug | butyl benzyl phthalate | 2.59e-05 | 32 | 41 | 3 | CID000002347 | |
| Drug | prodipine | 3.15e-05 | 5 | 41 | 2 | CID000065775 | |
| Drug | arginyl(PMC)-pyrrolidine-2-nitrile | 3.15e-05 | 5 | 41 | 2 | CID000487437 | |
| Drug | alanylproline-4-nitroanilide | 3.15e-05 | 5 | 41 | 2 | ctd:C083013 | |
| Drug | Cyproterone Acetate | 3.41e-05 | 35 | 41 | 3 | ctd:D017373 | |
| Drug | imazapyr | 4.04e-05 | 37 | 41 | 3 | CID000054738 | |
| Drug | Protease Inhibitors | 4.72e-05 | 6 | 41 | 2 | ctd:D011480 | |
| Drug | cathepsin C substrate | 4.72e-05 | 6 | 41 | 2 | CID003508173 | |
| Drug | NVP-DPP728 | 4.72e-05 | 6 | 41 | 2 | CID009796290 | |
| Drug | MK-251 | 4.72e-05 | 6 | 41 | 2 | CID000176160 | |
| Drug | chrysosplenetin | 4.72e-05 | 6 | 41 | 2 | CID005281608 | |
| Drug | II 19 | 4.72e-05 | 6 | 41 | 2 | CID000040321 | |
| Drug | NVP & EFV | 6.60e-05 | 121 | 41 | 4 | CID000492400 | |
| Drug | Epostatin | 6.61e-05 | 7 | 41 | 2 | CID006449105 | |
| Drug | Medroxyprogesterone | 6.61e-05 | 7 | 41 | 2 | ctd:D008525 | |
| Drug | o-Py | 6.61e-05 | 7 | 41 | 2 | CID009942336 | |
| Drug | triphenylethylene | 7.80e-05 | 46 | 41 | 3 | CID000006025 | |
| Drug | CID6451162 | 8.80e-05 | 8 | 41 | 2 | CID006451162 | |
| Drug | P32/98 | 8.80e-05 | 8 | 41 | 2 | CID006918464 | |
| Drug | imidazolelactate | 8.80e-05 | 8 | 41 | 2 | CID000000793 | |
| Drug | o-dianisidine | 1.00e-04 | 50 | 41 | 3 | CID000008411 | |
| Drug | ORG 2058 | 1.06e-04 | 51 | 41 | 3 | CID000119086 | |
| Drug | NSC-334212 | 1.13e-04 | 9 | 41 | 2 | CID000333414 | |
| Drug | Gly-pro-na | 1.13e-04 | 9 | 41 | 2 | CID000194319 | |
| Drug | U23,469 | 1.13e-04 | 9 | 41 | 2 | CID000161922 | |
| Drug | isoindoline | 1.13e-04 | 9 | 41 | 2 | CID000422477 | |
| Drug | Appna | 1.13e-04 | 9 | 41 | 2 | CID006453929 | |
| Drug | Phe-pro-ala | 1.13e-04 | 9 | 41 | 2 | CID000133668 | |
| Drug | SureCN475872 | 1.13e-04 | 9 | 41 | 2 | CID011163584 | |
| Drug | 4-tert-octylphenol | 1.26e-04 | 54 | 41 | 3 | CID000008814 | |
| Drug | N-phenylphthalimide | 1.41e-04 | 10 | 41 | 2 | CID000068215 | |
| Drug | Hxp | 1.41e-04 | 10 | 41 | 2 | CID000449159 | |
| Drug | X1043 | 1.41e-04 | 10 | 41 | 2 | CID011235728 | |
| Drug | mPDT | 2.06e-04 | 12 | 41 | 2 | CID006918514 | |
| Drug | trifluoroacetic acid | 2.09e-04 | 64 | 41 | 3 | CID000006422 | |
| Drug | 4-nonylphenol | 2.09e-04 | 64 | 41 | 3 | CID000001752 | |
| Drug | chlordecone | 2.40e-04 | 67 | 41 | 3 | CID000000299 | |
| Drug | ketononestrol aziridine | 2.44e-04 | 13 | 41 | 2 | CID000130642 | |
| Drug | DP-TAT-59 | 2.44e-04 | 13 | 41 | 2 | CID003037015 | |
| Drug | sampatrilat | 2.44e-04 | 13 | 41 | 2 | CID006324648 | |
| Drug | 17-alpha-hydroxy-progesterone caproate | 2.44e-04 | 13 | 41 | 2 | ctd:C020365 | |
| Drug | 4-nitroaniline | 2.44e-04 | 13 | 41 | 2 | ctd:C019498 | |
| Drug | Gly-pro-mca | 2.44e-04 | 13 | 41 | 2 | CID000125640 | |
| Drug | 1wvj | 2.61e-04 | 69 | 41 | 3 | CID005288598 | |
| Drug | 4-bromophenol | 2.73e-04 | 70 | 41 | 3 | CID000007808 | |
| Drug | AC1MHZPD | 2.84e-04 | 14 | 41 | 2 | CID003035635 | |
| Drug | 7-amino-4-trifluoromethylcoumarin | 2.84e-04 | 14 | 41 | 2 | CID000100641 | |
| Drug | AC1L4NWK | 3.27e-04 | 15 | 41 | 2 | CID000189017 | |
| Drug | AC1L322F | 3.27e-04 | 15 | 41 | 2 | CID000133040 | |
| Drug | Rifabutin [72559-06-9]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 3.31e-04 | 184 | 41 | 4 | 4349_DN | |
| Drug | 2f34 | 3.59e-04 | 188 | 41 | 4 | CID006420160 | |
| Drug | TAT-59 | 3.74e-04 | 16 | 41 | 2 | CID003034829 | |
| Drug | OH-PCB 30 | 3.74e-04 | 16 | 41 | 2 | CID000105036 | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.81e-04 | 191 | 41 | 4 | 991_DN | |
| Drug | 4-hydroxyestradiol | 3.90e-04 | 79 | 41 | 3 | CID000001743 | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 6971_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 5604_DN | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 4701_UP | |
| Drug | Dicloxacillin sodium salt [13412-64-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 4.45e-04 | 199 | 41 | 4 | 3307_DN | |
| Drug | Clonidine hydrochloride [4205-91-8]; Down 200; 15uM; MCF7; HT_HG-U133A | 4.45e-04 | 199 | 41 | 4 | 6814_DN | |
| Drug | AC1NRATE | 4.51e-04 | 83 | 41 | 3 | CID005288086 | |
| Drug | coproporphyrin I | 4.75e-04 | 18 | 41 | 2 | CID000068271 | |
| Drug | His-Ser | 4.75e-04 | 18 | 41 | 2 | CID000435727 | |
| Disease | hyperprolactinemia (is_implicated_in) | 1.61e-06 | 2 | 38 | 2 | DOID:12700 (is_implicated_in) | |
| Disease | Mammary Carcinoma, Animal | 8.14e-04 | 142 | 38 | 3 | C1257925 | |
| Disease | Animal Mammary Neoplasms | 8.14e-04 | 142 | 38 | 3 | C0024667 | |
| Disease | word list delayed recall measurement, memory performance | 8.31e-04 | 33 | 38 | 2 | EFO_0004874, EFO_0006805 | |
| Disease | hyperthyroidism | 9.35e-04 | 35 | 38 | 2 | EFO_0009189 | |
| Disease | Mammary Neoplasms, Experimental | 1.05e-03 | 155 | 38 | 3 | C0024668 | |
| Disease | Carcinomatosis | 1.21e-03 | 163 | 38 | 3 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 1.21e-03 | 163 | 38 | 3 | C0205697 | |
| Disease | Undifferentiated carcinoma | 1.21e-03 | 163 | 38 | 3 | C0205698 | |
| Disease | Anaplastic carcinoma | 1.21e-03 | 163 | 38 | 3 | C0205696 | |
| Disease | Carcinoma | 1.23e-03 | 164 | 38 | 3 | C0007097 | |
| Disease | monocyte percentage of leukocytes | 2.35e-03 | 731 | 38 | 5 | EFO_0007989 | |
| Disease | hippocampal atrophy | 2.38e-03 | 56 | 38 | 2 | EFO_0005039 | |
| Disease | idiopathic pulmonary fibrosis | 2.46e-03 | 57 | 38 | 2 | EFO_0000768 | |
| Disease | susceptibility to hepatitis A infection measurement | 3.49e-03 | 68 | 38 | 2 | EFO_0008415 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SCFSFPKPPVDPAKI | 111 | Q8NEN0 | |
| PGFKFIPEDPKVCTD | 146 | P48960 | |
| FKAEPPGKPSAFEPA | 631 | Q9BXX3 | |
| VFCFDPKYGEPKRPP | 251 | A6NDP7 | |
| KFVPTDCPPAFFPLA | 566 | P53671 | |
| FPAKPEEFPPITKCS | 296 | Q5U5R9 | |
| AFKVFGFKPPIPVPE | 276 | Q6PCE3 | |
| CFPIMFPPNDPKAGT | 256 | P22079 | |
| APPDCFPDKVKAFGP | 661 | Q14315 | |
| PFPPESCFQEGAPKR | 211 | P12525 | |
| PFKPASGKPDDTFCF | 346 | Q9UK32 | |
| GDFPDCAYPPDAEPK | 356 | P06401 | |
| PFSPGEDEFKCPIKE | 471 | Q86TI2 | |
| GGLPAPSDFKCPIKE | 496 | Q6V1X1 | |
| ENAFPPAGKKALPDC | 111 | P78396 | |
| APCAPGFKDDTKGPL | 156 | P35452 | |
| KEFPLPPVPKDCNFD | 266 | Q9UQ10 | |
| FQPFPGNDSPKEKDP | 806 | P42566 | |
| KPPPPDEFLDCFQKF | 321 | Q12929 | |
| FGCPPGRKEKPSDPV | 446 | Q6SPF0 | |
| KCFNPPPKPEPFQFG | 86 | Q9H814 | |
| FFPPKKSHGSCAPPV | 216 | Q8N2A8 | |
| EPPKCKDFVPFGKGI | 316 | Q8NBS3 | |
| CPPDPAKKLLGEPFV | 466 | Q96GJ1 | |
| EPYIKCAECGPPPFF | 26 | O75478 | |
| KFDFDACNEVPPAPK | 356 | Q15424 | |
| PPKCPPDTFGKDFFE | 1856 | Q6Q759 | |
| CEDGPVFYPPPKKTK | 241 | O00584 | |
| PPQPPVDVCLKKGDF | 856 | Q9NRJ4 | |
| KPFPCPFPGCGKIFA | 326 | O60481 | |
| YLPPECFVVGKEPPK | 636 | Q9UKI8 | |
| DDYPSSPPKCKFEPP | 66 | P63279 | |
| CEDGPFGPPPEEKKR | 701 | Q86TI0 | |
| CIFPPVPGPKIKGFD | 266 | P16471 | |
| KKTPPEDCEGPFRPA | 586 | P49790 | |
| GKPFDQALDPAKDPC | 76 | Q9BQ16 | |
| EKPFPCPFPGCGKVF | 201 | Q8N9L1 | |
| TGEKPFPCPDCGKRF | 396 | A6NFI3 | |
| KFRPAFPTGPKVPFC | 356 | Q9ULC8 | |
| GFSLPGPKADCDKIP | 316 | Q7Z4V0 | |
| KPFPCPFPGCGKVFA | 331 | O95409 |